UNSPSC 51112519: Metamelfalan

This classification denotes a nitrogen mustard compound with the molecular formula C13H18Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3B30XBE7S2, chemically known as l-phenylalanine, 3-(bis(2-chloroethyl)amino)- (9ci) but more generally known as metamelfalan, which bears US NIH Compound Identifier 14152. European Medicines Agency schedules Metamelfalan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08806MIG.

UNSPSC 51112519 Metamelfalan is a Commodity code covering a chemotherapy agent used in cancer treatment. State and local governments procure this pharmaceutical through health departments, correctional health systems, cancer treatment centers operated by counties or municipalities, and hospital networks managed by public entities. The drug is typically purchased as part of broader oncology medication inventories or specialized treatment protocols, often through group purchasing organizations or state pharmaceutical contracts that aggregate demand across multiple public health facilities. Procurement occurs both as standalone purchases for specific patient populations and as line-item additions to larger health-system formulary contracts.

The recent-opportunities block provided no entries for this code, indicating minimal posted solicitation activity in state and local procurement over the period covered by the source. While pharmaceutical procurement is routine across public health systems nationwide, Metamelfalan specifically appears either to be sourced through standing state-level contracts, cooperative purchasing agreements, or direct-buy arrangements that do not generate visible RFP, RFQ, IFB, or ITT notices. Without recent posted opportunities, geographic concentration and issuing-body patterns cannot be characterized from available data.